|
|
|
Insider
Information: |
Bradsher Neal C |
Relationship: |
10% Owner |
City: |
Union City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
129,185 |
|
Indirect Shares
|
57,363,752 |
|
|
Direct
Value |
$1,120,584 |
|
|
Indirect Value
|
$471,546,606 |
|
|
Total
Shares |
57,492,937 |
|
|
Total
Value |
$472,667,190 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
60
|
50
|
Stock
price went up :
|
44
|
16
|
Stock
price went down : |
16
|
34
|
|
|
|
Gain/Loss Ratio : |
2.8
|
2.8
|
Percentage
Gain/Loss : |
9.9%
|
-929.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Questcor Pharmaceuticals Inc |
QCOR |
Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director, 10% Owner |
2024-02-06 |
87,628 |
2024-02-06 |
41,666,255 |
Premium* |
|
Comarco Inc |
CMRO |
10% Owner |
2017-09-15 |
15,500 |
2017-09-15 |
0 |
Premium* |
|
STAAR Surgical Co |
STAA |
10% Owner |
2024-05-09 |
25,900 |
2024-05-09 |
10,768,431 |
Premium* |
|
Palomar Medical Technologies Inc |
PMTI |
10% Owner |
2013-06-24 |
0 |
2013-06-24 |
0 |
Premium* |
|
Asterias Biotherapeutics Inc |
AST |
See Remarks Below |
2019-03-08 |
0 |
2019-03-08 |
0 |
Premium* |
|
Oncocyte Corp |
OCX |
10% Owner |
2024-04-11 |
157 |
2024-04-11 |
4,929,066 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
612 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 23 of 25
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
STAA |
STAAR Surgical Co |
10% Owner |
|
2016-06-28 |
4 |
B |
$5.24 |
$30,375 |
D/D |
5,800 |
10,846,835 |
2.37 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2016-06-28 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
10,846,835 |
1.42 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2016-06-29 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
10,855,179 |
1.42 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2016-06-29 |
4 |
B |
$5.24 |
$43,706 |
D/D |
8,344 |
10,855,179 |
2.37 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2019-09-11 |
4 |
B |
$1.66 |
$3,320,000 |
D/D |
2,000,000 |
11,098,267 |
2.45 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2019-09-11 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
11,098,267 |
1.42 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-05-01 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
11,822,262 |
2.17 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-05-01 |
4 |
B |
$2.52 |
$5,040,000 |
D/D |
2,000,000 |
11,822,262 |
3.92 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-05-08 |
4 |
B |
$2.44 |
$730,500 |
D/D |
300,000 |
12,122,262 |
3.92 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-05-08 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
12,122,262 |
2.17 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-05-16 |
4 |
B |
$2.45 |
$735,000 |
D/D |
300,000 |
12,422,262 |
2.39 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-05-16 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
12,422,262 |
2.02 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-06-16 |
4 |
B |
$2.50 |
$2,500,000 |
D/D |
1,000,000 |
13,422,262 |
3.92 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-06-16 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
13,422,262 |
2.17 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2020-01-02 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
13,666,204 |
1.42 |
% |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2020-01-02 |
4 |
B |
$2.16 |
$3,000,001 |
D/D |
1,391,466 |
13,666,204 |
2.45 |
% |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-07-22 |
4 |
B |
$2.65 |
$980,500 |
D/D |
370,000 |
13,792,262 |
3.92 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-07-22 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
13,792,262 |
2.17 |
- |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2020-04-24 |
4 |
B |
$2.27 |
$2,383,500 |
D/D |
1,050,000 |
14,716,204 |
2.45 |
% |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2020-04-24 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
14,716,204 |
1.42 |
% |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2021-01-20 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,176,484 |
1.42 |
% |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2021-01-20 |
4 |
B |
$3.42 |
$4,999,999 |
D/D |
1,460,280 |
16,176,484 |
2.45 |
% |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2021-02-05 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
16,776,484 |
1.42 |
% |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2021-02-05 |
4 |
B |
$4.50 |
$2,700,000 |
D/D |
600,000 |
16,776,484 |
2.45 |
% |
|
OCX |
Oncocyte Corp |
10% Owner |
|
2021-09-23 |
4 |
OE |
$0.00 |
$0 |
I/I |
0 |
17,349,945 |
0 |
- |
|
612 Records found
|
|
Page 23 of 25 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|